Search for: "In Re Bd" Results 561 - 580 of 801
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Jul 2021, 10:05 pm by Jeff Richardson
  We don't know yet which case will be 1 F.4th 1, but it might possibly end up being this case that seems to have the lowest Westlaw citation number:  Nat'l Labor Relations Bd. v. [read post]
13 Jan 2010, 3:30 am by Joel Beck
  An informal action is one that is not reported on a firm's Form BD or an individual's Form U4. [read post]
25 Oct 2023, 9:24 am by Silverberg Zalantis LLC
The Appellate Division decision below is the latest in a line of cases interpreting Buran as limiting the relation back doctrine to mistakes regarding the identity or status of a proper party (see Matter of Nemeth, 205 AD3d at 1094-1095, citing, inter alia, Matter of Sullivan v Planning Bd. of the Town of Mamakating, 151 AD3d 1518, 1520 [3d Dept 2017]; Branch v Community Coll. of the County of Sullivan, 148 AD3d 1410, 1411-1412 [3d Dept 2017]; Matter of Ayuda Re Funding, LLC v Town… [read post]
31 Jul 2023, 7:28 am by Odia Kagan
Things the department can ask in an investigation: 1) Evidence re: AIS Program: The written AIS Program or any decision by the insurer not to develop and adopt a written AIS Program. [read post]
14 Dec 2017, 11:01 am by Steve Lubet
I would say they’re cockroaches, but that’s offensive to the cockroaches. [read post]
9 Mar 2011, 9:47 pm by Mike
Missouri Bd. of Probation & Parole,  (8th Cir. 1984) (per curiam)). [read post]
1 Jul 2021, 6:39 am by Steven Koprince
As stated in 13 C.F.R. 124.1001, “[a]ll current Participants in the 8(a) BD Program qualify as SDBs. [read post]
27 Jul 2023, 4:00 am by Heather Gray-Grant
Afterall, delegation and BD are required skills of a future Partner. [read post]
1 Apr 2010, 3:04 am
USPTO and Myriad Genetics (Docket Report) (Peter Zura's 271 Patent Blog) (Inventive Step) (Patently-O) (Holman's Biotech IP Blog) (Patent Docs) (Ladas & Parry) (Tech Transfer Blog) (ipwars.com) (Ars Technica) (BlawgIT) (IP Watch) (The Prior Art) US: Study suggests USPTO erred in broad claims of Myriad BRCA1 patent (Tech Transfer Blog) (Patent Docs) US: CAFC confirms written description requirement in Ariad v Lilly (IP Law Blog) (IP Osgoode) (IP Spotlight) (Ars Technica) US: Justifying… [read post]